The Journal of Pediatrics
Volume 146, Issue 1 , Pages 45-53 , January 2005

Growth hormone (GH) treatment to final height in children with idiopathic short stature: Evidence for a dose effect

Received 6 January 2004 ,Revised 12 July 2004 ,Accepted 23 August 2004.

References 

  1. Ranke MB. Towards a consensus on the definition of idiopathic short stature: summary. Horm Res. 1996;45(suppl 2):64–66
  2. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society: guidelines for the use of growth hormone in children with short stature. J Pediatr. 1995;127:857–867
  3. Guyda HJ. Growth hormone treatment of non-growth hormone deficient subjects: the International Task Force Report. Clin Pediatr Endocrinol. 1996;5(suppl 7):11–17
  4. Hindmarsh PC, Pringle PJ, Di Silvio L, Brook CG. Effects of 3 years of growth hormone therapy in short normal children. Acta Paediatr Scand. 1990;66(suppl 3):6–12
  5. Barton JS, Gardiner HM, Cullen S, Hindmarsh PC, Brook CGD, Preece MA. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature. Clin Endocrinol. 1995;42:619–626
  6. Hopwood NJ, Hintz RL, Gertner JM, Attie KM, Johanson AJ, Baptista J, et al. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr. 1993;123:215–222
  7. Guyda HJ. Four decades of growth hormone therapy for short children: what have we achieved?. J Clin Endocrinol Metab. 1999;84:4307–4316
  8. Zadik Z, Mira U, Landau H. Final height after growth hormone therapy in peripubertal boys with a subnormal integrated concentration of growth hormone. Horm Res. 1992;37:150–155
  9. Loche S, Cambiaso P, Setzu S, Carta D, Marini R, Borrelli P, et al. Final height after growth hormone therapy in non-growth hormone-deficient children with short stature. J Pediatr. 1994;125:196–200
  10. Hindmarsh PC, Brook CGD. Final height of short normal children treated with growth hormone. Lancet. 1996;348:13–16
  11. Lopez-Siguero JP, Martinez-Aedo MJ, Moreno-Molina JA. Final height after growth hormone therapy in children with idiopathic short stature and a subnormal growth rate. Acta Paediatr Suppl. 1996;417:121;Abstract
  12. Zadik Z, Segal N, Limony Y. Final height prediction models for pubertal boys. Acta Paediatr Suppl. 1996;417:53–56
  13. Bernasconi S, Street ME, Volta C, Mazzardo G, Italian Multicentre Study Group . Final height in non-growth hormone-deficient children treated with growth hormone. Clin Endocrinol. 1997;47:261–266
  14. Schmitt K, Blumel P, Waldhor T, Lassi M, Tulzer G, Frisch H. Short- and long-term (final height) data in children with normal variant short stature treated with growth hormone. Eur J Pediatr. 1997;156:680–683
  15. Zadik Z, Zung A. Final height after growth hormone therapy in short children: correlation with siblings' height. Horm Res. 1997;48:274–277
  16. Buchlis JG, Irizarry L, Crotzer BC, Shine BJ, Allen L, MacGillivray MH. Comparison of final heights of growth hormone-treated vs untreated children with idiopathic growth failure. J Clin Endocrinol Metab. 1998;83:1075–1079
  17. McCaughey ES, Mulligan J, Voss LD, Betts PR. Randomised trial of growth hormone in short normal girls. Lancet. 1998;351:940–944
  18. Hintz RL, Attie KM, Baptista J, Roche A. Effect of growth hormone treatment on adult height in children with idiopathic short stature. N Engl J Med. 1999;340:502–507
  19. Lanes R. Growth velocity, final height and bone mineral metabolism of short children treated long-term with growth hormone. Curr Pharm Biotechnol. 2000;1:33–46
  20. Lopez-Siguero JP, Garcia-Garcia E, Carralero I, Martinez-Aedo MJ. Adult height in children with idiopathic short stature treated with growth hormone. J Pediatr Endocrinol Metab. 2000;13:1595–1602
  21. Pasquino AM, Pucarelli I, Roggini M, Segni M. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone. J Clin Endocrinol Metab. 2000;85:619–622
  22. Wit JM, Rekers-Mombarg LT. Dutch Growth Hormone Advisory Group. Final height gain by GH therapy in children with idiopathic short stature is dose dependent. J Clin Endocrinol Metab. 2002;87:604–611
  23. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: A randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:3140–3148
  24. Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L. Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med. 2002;156:230–240
  25. Rekers-Mombarg LTM, Massa GG, Wit JM, Matranga AMC, Bucker JMH, Butenandt O, et al. Growth hormone therapy with three dosage regimens in children with idiopathic short stature. J Pediatr. 1998;132:455–460
  26. Rekers-Mombarg LTM, Rijkers GT, Massa GG, Wit JM. Dutch Growth Hormone Working Group: immunologic studies in children with idiopathic short stature before and during growth hormone therapy. Horm Res. 1995;44:203–207
  27. Rekers-Mombarg LTM, Kamp GA, Massa GG, Wit JM. Dutch Growth Hormone Working Group: influence of growth hormone treatment on pubertal timing and pubertal growth in children with idiopathic short stature. J Pediatr Endocrinol. 1999;12:611–622
  28. Rekers-Mombarg LTM, Busschbach J, Massa GG, Dicke J, Wit JM. Dutch Growth Hormone Working Group: quality of life of young adults with idiopathic short stature: effect of growth hormone treatment. Acta Paediatr. 1998;87:865–870
  29. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965 part II. Arch Dis Child. 1966;41:613–635
  30. Tanner JM, Whitehouse RH, Cameron N, Marshall WA, Healy MJR, Goldstein H. Assessment of Skeletal Maturity and Prediction of Adult Height (TW2-method). 2nd ed.. London: Academic Press; 1983;
  31. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291–303
  32. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13–23
  33. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. 2nd ed.. Stanford, Calf: Stanford University Press; 1959;
  34. Ruiz-Echam M, Rueda C, Labena C, Labarta J, Mayayo E, Ferrandez Longas A. Spanish longitudinal study of growth and development: bone maturation according to Greulich-Pyle and Tanner-Whitehouse 2-RUS methods from 6 months until 18 years of age. Presented at the 41st meeting of the European Society for Paediatric Endocrinology; 25-28 September 2002.
  35. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952;40:423–441
  36. Tanner JM, Whitehouse RH, Marshall WA, Carter BS. Predictions of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16 with allowance for midparent height. Arch Dis Child. 1975;50:14–26
  37. Prader A, Largo RH, Molinari L, Issler C. Physical growth of Swiss children from birth to 20 years of age: First Zurich Longitudinal Study of Growth and Development. Helv Paediatr Acta. 1989;(suppl 52):1–125
  38. Hintz RL, Attie KM, Baptista J, Roche A. Effect of growth hormone treatment on adult height in children with idiopathic short stature. N Engl J Med. 1999;340:502–507
  39. Bramswig JH, Fasse M, Holthoff ML, von Lengerke HJ, von Petrykowski W, Schellong G. Adult height in boys and girls with untreated short stature and constitutional delay of growth and puberty: accuracy of five different methods of height prediction. J Pediatr. 1990;117:886–891
  40. Maneatis T, Baptista J, Connelly K, Blethen S. Growth hormone safety update from the National Cooperative Growth Study. J Pediatr Endocrinol. 2000;13(suppl 2):1035–1044
  41. Wilton P. Adverse events during GH treatment: 10 years' experience in KIGS: a pharmacoepidemiological survey. In:  Ranke MB,  Wilton P editor. Growth Hormone Therapy in KIGS 10 Years' Experience. Heidelberg: Barth; 1999;p. 349–364
  42. Gerald WL, Ladany M, de Alava E, Cuatrecasas M, Kushner BH, LaQuaglia MP, et al. Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol. 1998;16:3028–3036
  43. Saenger P, Attie KM, DiMartino-Nardi J, Hintz R, Frahm L, Frane JW. Metabolic consequences of 5-year growth hormone (GH) therapy in children treated with GH for idiopathic short stature. J Clin Endocrinol Metab. 1998;83:3115–3120
  44. Quigley CA, Crowe BJ, Anglin DG, Chipman JJ. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab. 2002;87:2033–2041
  45. Ranke MB, Partsch CJ, Lindberg A, Dorr HG, Bettendorf M, Hauffa BP, et al. Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. Eur J Endocrinol. 2002;147:625–633

 G. B. Cutler, B. Crowe, T. J. Beck, K. Roberts, and A. Gill are employees and shareholders of Eli Lilly and Company, which sponsored this study. A. Attanasio is a consultant to and shareholder of Eli Lilly and Company. J. M. Wit, J.-L. Chaussain, H. Frisch, and R. Yturriaga were all principal investigators for this study.

PII: S0022-3476(04)00794-2

doi: 10.1016/j.jpeds.2004.08.055

The Journal of Pediatrics
Volume 146, Issue 1 , Pages 45-53 , January 2005

Article Tools

* Image Usage & Resolution